Rotavirus vaccines: considerations for successful implementation in Europe

Lancet Infectious Diseases

Volumn 6, Issue 12, 2006, Pages 805-812

  Van Damme, Pierre ^a   Van der Wielen, Marie ^a   Ansaldi, Filippo ^b   Desgrandchamps, Daniel ^c   Domingo, Javier Diez ^d   Sanchez, Francisco Gimenez ^e   Gray, Jim ^f   Haditsch, Martin ^g   Johansen, Kari ^h   Lorgelly, Paula ⁱ   Lorrot, Mathie ^j   Parez, Nathalie ^k   Reschke, Volkmar ^c   Rose, Markus ^l  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF GENOA   (Italy)

^c Vaccine Institute of Valencia ^*

^d Vaccine Institute of Valencia   (Spain)

^e Advisory Committee of Vaccines   (Spain)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g ELISABETHINEN HOSPITAL   (Austria)

^h SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j HÔPITAL ROBERT DEBRÉ   (France)

^k ARMAND TROUSSEAU HOSPITAL   (France)

^l GOETHE UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; COST OF ILLNESS; DRUG SAFETY; EUROPE; GASTROENTERITIS; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; IMMUNIZATION; INFECTION PREVENTION; PRIORITY JOURNAL; ROTAVIRUS; VIRUS INFECTION;

EID: 33845489787     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70657-0     Document Type: Note

References (80)

1. Offit P., and Clark H. Rotavirus. In: Mandell G., Bennett J., and Dolin R. (Eds). Principles and practice of infectious diseases. 5th edn. vol 2 (2000), Churchill Livingstone, New York 1969 1703
2. Clark H., Offit P., and Glass R. Rotavirus vaccines. In: Plotkin S., and Orenstein W. (Eds). Vaccines. 4th edn. (2004), Saunders/Elsevier, Philadelphia 1327-1345
3. Clark H., and Offit P. Vaccines for rotavirus gastroenteritis universally needed for infants. Pediatr Ann 338 (2004) 537-543
4. Glass R., Bresee J., Parashar U., et al. Rotavirus vaccines: past, present, and future. Arch Pediatr 12 (2005) 844-847
5. Velazquez F., Matson D., Calva J., et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335 (1996) 1022-1028
6. Anderson E., and Weber S. Rotavirus infection in adults. Lancet Infect Dis 4 (2004) 91-99
7. Roberts L. Rotavirus vaccines' second chance. Science 305 (2004) 1890-1893
8. Bonn D. New vaccines to fight killer rotavirus. Lancet Infect Dis 4 (2004) 658
9. Glass R., Parashar U., Bresee J., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 (2006) 323-332
10. Parashar U., Gibson C., Bresee J., and Glass R. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12 (2006) 304-306
11. Kilgore P., Holman R., Clarke M., and Glass R. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA 274 (1995) 1143-1148
12. Glass R., Kilgore P., Holman R., et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis 174 suppl 1 (1996) S5-S11
13. Parashar U., Hummelman E., Bresee J., Miller M., and Glass R. Global illness and deaths caused by rotavirus disease in children. Appendix B. Emerg Infect Dis 9 (2003). http://www.cdc.gov/ncidod/EID/vol9no5/02-0562_appB.htm (accessed Oct 16, 2006)
14. Glass R., Bresee J., Parashar U., Jiang B., and Gentsch J. The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 363 (2004) 1547-1550
15. Parashar U., Hummelman E., Bresee J., Miller M., and Glass R. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 (2003) 565-572
16. Glass R., Bresee J., Parashar U., Holman R., and Gentsch J. First rotavirus licensed: is there really a need?. Acta Paediatr Suppl 88 suppl 426 (1999) 2-8
17. Soriano-Gabarro M., Mrukowicz J., Vesikari T., and Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 25 suppl 1 (2006) S7-S11
18. Frühwirth M., Heininger U., Ehlken B., et al. International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. Pediatr Infect Dis J 20 (2001) 784-791
19. Hsu V., Staat M., Roberts N., et al. Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics 115 (2005) 78-82
20. Visser L., Cano Portero R., Gay N., and Martinez Navarro J. Impact of rotavirus disease in Spain: an estimate of hospital admissions due to rotavirus. Acta Paediatr Suppl 88 suppl 426 (1999) 72-76
21. De Wit M., Koopmans M., Van Der Blij J., and Van Duynhoven Y. Hospital admissions for rotavirus infection in the Netherlands. Clin Infect Dis 31 (2000) 698-704
22. Fischer T. Incidence of hospitalizations due to rotavirus gastroenteritis in Denmark. Acta Paediatr 90 (2001) 1073-1075
23. Johansen K., Bennet R., Bondesson K., et al. Incidence and estimates of the disease burden of rotavirus in Sweden. Acta Paediatr Suppl 88 suppl 426 (1999) 20-23
24. Ryan M., Ramsay M., Brown D., Gay N., Farrington C., and Wall P. Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis 174 suppl 1 (1996) S12-S18
25. Vesikari T., Rautanen T., and Von Bonsdorff C. Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features. Acta Paediatr Suppl 88 suppl 426 (1999) 24-30
26. Poppe M., Ehlken B., Rohwedder A., et al. Morbidity and hospital admissions due to rotavirus infection in Germany. Monatsschr Kinderheilkd 150 (2002) 491-496 (in German)
27. Lynch M., O'Halloran F., Whyte D., Fanning S., Cryan B., and Glass R. Rotavirus in Ireland: national estimates of disease burden, 1997 to 1998. Pediatr Infect Dis J 20 (2001) 693-698
28. Szucs G., Uj M., Mihaly I., and Deak J. Burden of human rotavirus-associated hospitalisations in three geographic regions of Hungary. Acta Paediatr Suppl 88 suppl 426 (1999) 61-65
29. Gil A., Carrasco P., Jimenez R., San-Martin M., Oyaguez I., and Gonzalez A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 22 (2004) 2221-2225
30. Mrukowicz J., Krobicka B., Duplaga M., et al. Epidemiology and impact of rotavirus diarrhoea in Poland. Acta Paediatr Suppl 88 suppl 426 (1999) 53-60
31. Fourquet F., Desenclos J., Maurage C., and Baron S. Acute gastro-enteritis in children in France: estimates of disease burden through national hospital discharge data. Arch Pediatr 10 (2003) 861-868 (in French)
32. Noone C., and Banatvala J. Hospital acquired rotaviral gastroenteritis in a general paediatric unit. J Hosp Infect 4 (1983) 297-299
33. Berner R., Schumacher R., Hameister S., and Forster J. Occurrence and impact of community-acquired and nosocomial rotavirus infections-a hospital-based study over 10 years. Acta Paediatr 88 suppl 426 (1999) 48-52
34. Pina P., Le Huidoux P., Lefflot S., et al. Nosocomial rotavirus infection in a general pediatric ward: epidemiology, molecular typing and risk factors. Arch Pediatr 7 (2000) 1050-1058 (in French)
35. Grimprel E., Parez N., Gault E., Garbarg-Chenon A., and Begue P. Acute diarrhea and rotavirus infection in the child: assessment of data from emergency care and the microbiology laboratory of the Armand-Trousseau (Paris) hospital between 1988 and 2001. Arch Pediatr 8 (2001) 1318-1324 (in French)
36. Moulin F., Marc E., Lorrot M., et al. Hospitalization due to rotavirus acute gastroenteritis: a four-year survey. Arch Pediatr 9 (2002) 255-261 (in French)
37. Melliez H., Boelle P.-Y., Baron S., Mouton Y., and Yazdanpanah Y. Mortality, morbidity, and cost of rotavirus infections in France. BEH 35 (2005) 175-176 (in French)
38. Frühwirth M., Berger K., Ehlken B., Moll-Schüler I., Brösl S., and Mutz I. Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria. Pediatr Infect Dis J 20 (2001) 184-188
39. Harrington M., Butler K., and Cafferkey M. Rotavirus infection in hospitalised children: incidence and impact on health-care resources. Irish J Med Sci 172 (2003) 33-36
40. Ehlken B., Laubereau B., Karmaus W., et al. Prospective population-based study on rotavirus disease in Germany. Acta Paediatr 91 (2002) 769-775
41. Frühwirth M., Karmaus W., Moll-Schüler I., Brösl S., and Mutz I. A prospective evaluation of community acquired gastroenteritis in paediatric practices: impact and disease burden of rotavirus infection. Arch Dis Child 84 (2001) 393-397
42. Cilla G., Perez-Trallero E., Lopez-Lopategui M., Gilsetas A., and Gomariz M. Incidence, seasonality and serotypes of rotavirus in Gipuzkoa (Basque Country), Spain. A 14-year study. Epidemiol Infect 125 (2000) 677-683
43. Djuretic T., Ramsay M., Gay N., Wall P., Ryan M., and Flerming D. An estimate of the proportion of diarrhoeal episodes seen by general practitioners attributable to rotavirus in children under 5 years of age in England and Wales. Acta Paediatr 88 suppl 426 (1999) 38-41
44. Koopmans M., and Brown D. Seasonality and diversity of group A rotaviruses in Europe. Acta Paediatr 88 suppl 426 (1999) 14-19
45. Hjelt K. Nosocomial virus infections in pediatric departments: rotavirus and respiratory syncytial virus. Ugeskr Laeger 153 (1991) 2102-2104 (in Danish)
46. Maille L., Beby-Defaux A., Bourgoin A., et al. Nosocomial infections due to rotavirus and respiratory syncytial virus in pediatric wards: a 2-year survey. Ann Biol Clin 58 (2000) 601-606 (in French)
47. Le Roux P., Marshall B., Toutain F., et al. Nosocomial infections in a pediatric ward: epidemiology and quality research. Arch Pediatr 11 (2004) 908-915 (in French)
48. Ratner A., Neu N., Jakob K., et al. Nosocomial rotavirus in a pediatric hospital. Infect Control Hosp Epidemiol 22 (2001) 299-301
49. Widdowson M., van Doornum G., van der Poel W., et al. An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: investigation using both epidemiologic and microbiological methods. Infect Control Hosp Epidemiol 23 (2002) 665-670
50. Dennehy P. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis J 19 suppl 10 (2000) S103-S105
51. Fischer T., and Molbak K. The cost of an outbreak-an example from a Danish day care setting. Vaccine 20 (2002) 637-638
52. Edmonson L., Ebert J., and Evans J. Report of a rotavirus outbreak in an adult nursing home population. J Am Med Dir Assoc 1 (2000) 175-179
53. Gellert G., Waterman S., Ewert D., et al. An outbreak of acute gastroenteritis caused by a small round structured virus in a geriatric convalescent facility. Infect Control Hosp Epidemiol 11 (1990) 459-464
54. Fischer T., Bresee J., and Glass R. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22 suppl 1 (2004) S49-S54
55. Thuret A., Patural H., Berthelot P., et al. Prospective follow-up of hospital-acquired diarrhea in 28 paediatric wards of the south-east part of France during a winter season. Pathol Biol 52 (2004) 131-137 (in French)
56. Sermet-Gaudelus I., de La Rocque F., Salomon J., et al. Rotavirus nosocomial infection in pediatric units. A multicentric observation study. Pathol Biol 52 (2004) 4-10 (in French)
57. Smith J., Haddix A., Teutsch S., and Glass R. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Pediatrics 96 (1995) 609-615
58. Tucker A., Haddix A., Bresee J., Holman R., Parashar U., and Glass R. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279 (1998) 1371-1376
59. Lorgelly PK, Joshi D, Iturriza Gomara M, et al. Infantile gastroenteritis in the community: a cost of illness study. 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases; Valencia, Spain; May 18-20, 2005.
60. Fontana M., Zuin G., Pancheri P., et al. Costs associated with outpatient diarrhoea in infants and toddlers: a nationwide study of the Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP). Dig Liver Dis 36 (2004) 523-527
61. Piednoir E., Bessaci K., Bureau-Chalot F., et al. Economic impact of healthcare-associated rotavirus infection in a paediatric hospital. J Hosp Infect 55 (2003) 190-195
62. Murphy T., Smith P., Gargiullo P., and Schwartz B. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J Infect Dis 187 (2003) 1309-1313
63. Murphy T., Gargiullo P., Massoudi M., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344 (2001) 564-572
64. Bines J. Rotavirus vaccines and intussusception risk. Curr Opin Gastroenterol 21 (2005) 20-25
65. Simonsen L., Viboud C., Elixhauser A., Taylor R., and Kapikian A. More on RotaShield and intussusception: the role of age and the time of vaccination. J Infect Dis 192 suppl 1 (2005) S36-S43
66. Santos N., and Hoschino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15 (2005) 29-56
67. Lorrot M., Bon F., Balay K., et al. Rotavirus sero/genotypes in France and worldwide. Arch Pediatr 12 (2005) 838-840 (in French)
68. Gentsch J., Laird A., Bielfelt B., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192 suppl 1 (2005) S146-S159
69. Cunliffe N., and Nakagomi O. A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 4 (2005) 521-532
70. Desselberger U., Wolleswinkel-van den Bosch J., Mrukowicz J., Rodrigo C., Giaquinto C., and Vesikari T. Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J 25 suppl 1 (2006) S30-S41
71. Heaton P., Goveia M., Miller J., Offit P., and Clark H. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 192 suppl 1 (2005) S17-S21
72. Ruiz-Palacios G., Perez-Schael I., Velazquez F., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 (2006) 11-22
73. Vesikari T., Matson D., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 (2006) 23-33
74. WHO. Global Advisory Committee on Vaccine Safety, 1-2 December 2005. Wkly Epidemiol Rec 2 (2006) 15-19
75. Phua K., Quak S., Lee B., et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 192 suppl 1 (2005) S6-S16
76. Diez-Domingo J., Pereiro I., Morant A., et al. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: Experience in the autonomous region of Valencia, Spain. J Infect 42 (2001) 257-260
77. Pereiro I., Diez-Domingo J., Morant A., et al. Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine. Scand J Infect Dis 33 (2001) 581-584
78. European Vaccine Manufacturers. European survey regarding the perception of vaccines and vaccinations. http://www.evm-vaccines.org/pdfs/survey_perceptions_fin.pdf (accessed Oct 16, 2006)
79. Navarro Alonso J., Gonzalez P., and Carbonell J. Analysis of factors influencing vaccine uptake: perspective from Spain. Vaccine 20 suppl 1 (2001) S13-S15
80. Balinska M. Vaccination in tomorrow's society. Lancet Infect Dis 3 (2003) 443-447